Open AccessEfficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Author(s) -
Fredrik Piehl,
Ann Eriksson-Dufva,
Anna Budzianowska,
Amalia Feresiadou,
William Hansson,
Max Albert Hietala,
Irene Håkansson,
Rune Johansson,
Daniel Jons,
Ivan Kmezic,
Christopher Lindberg,
Jonas Lindh,
Fredrik Lundin,
Ingela Nygren,
Anna Rostedt Punga,
Rayomand Press,
Kristin Samuelsson,
Peter Sundström,
Oskar Wickberg,
Susanna Brauner,
Thomas Frisell
Publication year - 2022
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2022.2887
Subject(s) - rituximab , medicine , placebo , myasthenia gravis , clinical endpoint , randomized controlled trial , surgery , alternative medicine , pathology , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom